West Paces Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.86K | Buy |
+30
| New | +$2.88K | ﹤0.01% | 529 |
|
|
2025
Q2 | – | Sell |
-40
| Closed | -$5.89K | – | 280 |
|
|
2025
Q1 | $5.89K | Hold |
40
| – | – | ﹤0.01% | 372 |
|
|
2024
Q4 | $6.5K | Hold |
40
| – | – | ﹤0.01% | 373 |
|
|
2024
Q3 | $6.52K | Hold |
40
| – | – | ﹤0.01% | 376 |
|
|
2024
Q2 | $5.46K | Hold |
40
| – | – | ﹤0.01% | 388 |
|
|
2024
Q1 | $6.12K | Sell |
40
-3
| -7% | -$448 | ﹤0.01% | 393 |
|
|
2023
Q4 | $6.13K | Buy |
43
+3
| +8% | +$400 | ﹤0.01% | 397 |
|
|
2023
Q3 | $5.24K | Hold |
40
| – | – | ﹤0.01% | 393 |
|
|
2023
Q2 | $6.36K | Hold |
40
| – | – | ﹤0.01% | 403 |
|
|
2023
Q1 | $6.33K | Buy |
+40
| New | +$6K | ﹤0.01% | 403 |
|
|
2022
Q4 | – | Sell |
-15
| Closed | -$1.93K | – | 540 |
|
|
2022
Q3 | $1.93K | Hold |
15
| – | – | ﹤0.01% | 439 |
|
|
2022
Q2 | $2.12K | Hold |
15
| – | – | ﹤0.01% | 490 |
|
|
2022
Q1 | $2.08K | Hold |
15
| – | – | ﹤0.01% | 485 |
|
|
2021
Q4 | $2.62K | Sell |
15
-30
| -67% | -$5K | ﹤0.01% | 499 |
|
|
2021
Q3 | $7.45K | Hold |
45
| – | – | ﹤0.01% | 386 |
|
|
2021
Q2 | $8.1K | Hold |
45
| – | – | ﹤0.01% | 379 |
|
|
2021
Q1 | $8.68K | Hold |
45
| – | – | ﹤0.01% | 344 |
|
|
2020
Q4 | $9.09K | Hold |
45
| – | – | ﹤0.01% | 326 |
|
|
2020
Q3 | $9.46K | Hold |
45
| – | – | ﹤0.01% | 307 |
|
|
2020
Q2 | $9.87K | Hold |
45
| – | – | 0.01% | 315 |
|
|
2020
Q1 | $7.8K | Hold |
45
| – | – | ﹤0.01% | 329 |
|
|
2019
Q4 | $6.91K | Hold |
45
| – | – | ﹤0.01% | 380 |
|
|
2019
Q3 | $6.83K | Hold |
45
| – | – | ﹤0.01% | 358 |
|
|
2019
Q2 | $6.89K | Hold |
45
| – | – | ﹤0.01% | 351 |
|
|
2019
Q1 | $7.22K | Hold |
45
| – | – | 0.01% | 346 |
|
|
2018
Q4 | $6.94K | Hold |
45
| – | – | 0.01% | 346 |
|
|
2018
Q3 | $6.77K | Hold |
45
| – | – | ﹤0.01% | 359 |
|
|
2018
Q2 | $6.09K | Sell |
45
-14
| -24% | -$1.73K | ﹤0.01% | 372 |
|
|
2018
Q1 | $7.85K | Hold |
59
| – | – | 0.01% | 338 |
|
|
2017
Q4 | $8.78K | Hold |
59
| – | – | 0.01% | 355 |
|
|
2017
Q3 | $7.78K | Hold |
59
| – | – | 0.01% | 357 |
|
|
2017
Q2 | $7.86K | Hold |
59
| – | – | 0.01% | 356 |
|
|
2017
Q1 | $7.96K | Sell |
59
-8
| -12% | -$1.04K | 0.01% | 352 |
|
|
2016
Q4 | $8.04K | Buy |
+67
| New | +$7.9K | 0.01% | 361 |
|
Other funds holding CLX
West Paces Advisors's CLX Position: Q2 2026 in Review
West Paces Advisors opened a new position in Clorox (CLX) in Q2 2026: 30 shares worth $2.86K. The stake represents ﹤0.01% of the portfolio and ranks #529 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in CLX as recently as Q1 2025.
West Paces Advisors first reported a position in CLX in Q4 2016 and has held it in 34 quarters since. The position peaked at $9.87K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- West Paces Advisors held 30 shares of Clorox worth $2.86K as of Q2 2026.
- Clorox was a new West Paces Advisors position in Q2 2026.
- Clorox made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #529 holding.
- West Paces Advisors first reported a position in Clorox in Q4 2016 and has held it in 34 quarters since.
- West Paces Advisors's Clorox position peaked at $9.87K in Q2 2020.
- 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.